OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

HTML

Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(10)60888-4
Authors: Frank L Greenway, Ken Fujioka, Raymond A Plodkowski, Sunder Mudaliar, Maria Guttadauria, Janelle Erickson, Dennis D Kim, Eduardo Dunayevich
Institutions: Pennington Biomedical Research Center, Louisiana State University System, Scripps Clinic, University of Nevada, Reno, VA Sierra Nevada Health Care System, University of California San Diego, VA San Diego Healthcare System, Orexigen Therapeutics (United States)
Language: English

Topic: Pharmacology and Obesity Treatment
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: naltrexone, bupropion, Contrave, obesity, weight loss, combination pharmacotherapy, sustained-release formulation, dose escalation, body mass index, dyslipidemia, hypertension, hypocaloric diet, physical activity, weight loss maintenance, relapse prevention, adverse events, drug safety, antidepressant side effects, opioid antagonists
SDG: Good health and well-being

Open Access status: closed

Funder: Orexigen Therapeutics
OpenAlex ID: W2110438413
FWCI: 30.03
Cites: 30
Cited by: 1,169
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security